Instem (LSE:INS) Dividend Payout Ratio : 0.00 (As of Jun. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Instem Dividend Payout Ratio?

Instem's dividend payout ratio for the months ended in Jun. 2023 was 0.00.

The historical rank and industry rank for Instem's Dividend Payout Ratio or its related term are showing as below:

LSE:INS's Dividend Payout Ratio is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 0.375
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-10), the Dividend Yield % of Instem is 0.00%.

Instem's Dividends per Share for the months ended in Jun. 2023 was £0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Instem Dividend Payout Ratio Historical Data

The historical data trend for Instem's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instem Dividend Payout Ratio Chart

Instem Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dividend Payout Ratio

Get a 7-Day Free Trial

Instem Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Instem's Dividend Payout Ratio

For the Health Information Services subindustry, Instem's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Instem's Dividend Payout Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Instem's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Instem's Dividend Payout Ratio falls into.

Instem Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Instem's Dividend Payout Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2022 )	/	EPS without NRI (A: Dec. 2022 )
	=	0	/	0.313
	=	0.00

Instem's Dividend Payout Ratio for the quarter that ended in Jun. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2023 )	/	EPS without NRI (Q: Jun. 2023 )
	=	0	/	0.123
	=	0.00

Instem (LSE:INS) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Instem Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Instem's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Instem (LSE:INS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Instem PLC (LSE:INS) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

Diamond Way, Stone Business Park, Stone, Staffordshire, GBR, ST15 0SD

Website

https://www.instem.com

Instem PLC acts as a supplier of IT applications and technology-enabled outsourced services to the global health and life sciences community. Its segments include Study Management, Regulatory Solutions, and In Silico Solutions, Clinical Trial Acceleration. The company generates maximum revenue from Study Management. Geographically, it derives a majority of its revenue from the United States and also has a presence in the Europe and Rest of the World. Its portfolio of software solutions includes Instem Cloud, SEND Data Conversion, KnowledgeScan, SENDReady Consulting, Solution Deployment, Validation, Data Management, and Regulatory Information Management.

Instem (LSE:INS) Headlines

No Headlines